These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1365 related articles for article (PubMed ID: 16087298)

  • 41. Complications that affect postlaryngectomy voice restoration: primary surgery vs salvage surgery.
    Starmer HM; Ishman SL; Flint PW; Bhatti NI; Richmon J; Koch W; Webster K; Tufano R; Gourin CG
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1165-9. PubMed ID: 19917932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Voice and swallowing disorders: functional results and quality of life following supracricoid laryngectomy with cricohyoidoepiglottopexy.
    Portas JG; Queija Ddos S; Arine LP; Ferreira AS; Dedivitis RA; Lehn CN; Barros AP
    Ear Nose Throat J; 2009 Oct; 88(10):E23-30. PubMed ID: 19826987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salvage laryngectomy for failed conservative treatment of laryngeal cancer.
    Young VN; Mangus BD; Bumpous JM
    Laryngoscope; 2008 Sep; 118(9):1561-8. PubMed ID: 18677280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional status after total laryngectomy: cross-sectional survey of 79 laryngectomees using the Performance Status Scale for Head and Neck Cancer.
    Oozeer NB; Owen S; Perez BZ; Jones G; Welch AR; Paleri V
    J Laryngol Otol; 2010 Apr; 124(4):412-6. PubMed ID: 20003587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.
    Lefebvre JL; Ang KK;
    Head Neck; 2009 Apr; 31(4):429-41. PubMed ID: 19283793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of quality of life in advanced laryngeal cancer patients after concurrent chemoradiotherapy vs total laryngectomy.
    Trivedi NP; Swaminathan DK; Thankappan K; Chatni S; Kuriakose MA; Iyer S
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):702-7. PubMed ID: 18984267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation.
    Boscolo-Rizzo P; Maronato F; Marchiori C; Gava A; Da Mosto MC
    Laryngoscope; 2008 Feb; 118(2):300-6. PubMed ID: 18030164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
    Jones AS; Fish B; Fenton JE; Husband DJ
    Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.
    Agrawal A; Moon J; Davis RK; Sakr WA; Giri SP; Valentino J; LeBlanc M; Truelson JM; Yoo GH; Ensley JF; Schuller DE;
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1044-50. PubMed ID: 17938330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
    Lefebvre JL; Ang KK;
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy.
    Al-Mamgani A; Tans L; van Rooij P; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1000-6. PubMed ID: 22099030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
    Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT
    Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
    McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
    Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Speech intelligibility and quality of life in head and neck cancer survivors.
    Meyer TK; Kuhn JC; Campbell BH; Marbella AM; Myers KB; Layde PM
    Laryngoscope; 2004 Nov; 114(11):1977-81. PubMed ID: 15510026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
    Cmelak AJ; Murphy BA; Burkey B; Douglas S; Shyr Y; Netterville J
    Head Neck; 2007 Apr; 29(4):315-24. PubMed ID: 17252600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
    Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.